David A. Barbie

1996–2025 年に発表

92
論文数
23,016
被引用数
59
h 指数
88
i10 指数

被引用数

David A. Barbie の年別被引用数1976 年: 被引用 1 件1997 年: 被引用 6 件1998 年: 被引用 3 件1999 年: 被引用 5 件2000 年: 被引用 17 件2001 年: 被引用 43 件2002 年: 被引用 60 件2003 年: 被引用 55 件2004 年: 被引用 41 件2005 年: 被引用 50 件2006 年: 被引用 53 件2007 年: 被引用 41 件2008 年: 被引用 41 件2009 年: 被引用 51 件2010 年: 被引用 106 件2011 年: 被引用 109 件2012 年: 被引用 89 件2013 年: 被引用 93 件2014 年: 被引用 100 件2015 年: 被引用 132 件2016 年: 被引用 203 件2017 年: 被引用 192 件2018 年: 被引用 273 件2019 年: 被引用 934 件2020 年: 被引用 1,287 件2021 年: 被引用 1,468 件2022 年: 被引用 1,338 件2023 年: 被引用 1,170 件2024 年: 被引用 1,683 件2025 年: 被引用 1,013 件2026 年: 被引用 41 件1977〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,519 件、この内訳の 30.6%中国: 引用元論文 2,702 件、この内訳の 18.3%イギリス: 引用元論文 769 件、この内訳の 5.2%ドイツ: 引用元論文 670 件、この内訳の 4.5%イタリア: 引用元論文 531 件、この内訳の 3.6%フランス: 引用元論文 474 件、この内訳の 3.2%カナダ: 引用元論文 417 件、この内訳の 2.8%日本: 引用元論文 400 件、この内訳の 2.7%オーストラリア: 引用元論文 358 件、この内訳の 2.4%スペイン: 引用元論文 355 件、この内訳の 2.4%オランダ: 引用元論文 318 件、この内訳の 2.2%スイス: 引用元論文 316 件、この内訳の 2.2%
0%30.6%その他 19.9%

分野

  • Medicine48.1%
  • Biochemistry, Genetics and Molecular Biology34.6%
  • Immunology and Microbiology12.6%
  • Engineering2.3%
  • Computer Science0.5%
  • Chemistry0.5%
  • その他1.4%

トピック

  • Cancer Immunotherapy and Biomarkers9%
  • Immunotherapy and Immune Responses4.1%
  • CAR-T cell therapy research3.5%
  • Immune Cell Function and Interaction3.5%
  • Cancer Genomics and Diagnostics3.2%
  • Immune cells in cancer3%
  • その他73.7%

共著者

全論文

検索で開く
  1. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jill P. Mesirov, David E. Root, D. Gary Gilliland, Tyler Jacks, William C. Hahn - Nature 2009 被引用: 4,263

  2. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer A. Wargo, Genevieve M. Boland, Ryan J. Sullivan, Gad Getz, Nir Hacohen - Cell 2018 被引用: 2,103

  3. A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Israel Cañadas, Bastian Schilling, Adam N.R. Cartwright, Adrienne Luoma, Shruti Malu, Patrick Hwu, Chantale Bernatchez, Marie-Andrée Forget, David A. Barbie, Alex K. Shalek, Itay Tirosh, Peter K. Sorger, Kai W. Wucherpfennig, Eliezer M. Van Allen, Dirk Schadendorf, Bruce E. Johnson, Asaf Rotem, Orit Rozenblatt–Rosen, Levi A. Garraway, Charles H. Yoon, Benjamin Izar, Aviv Regev - Cell 2018 被引用: 1,482

  4. Mechanisms of resistance to immune checkpoint inhibitors

    著者: , , - British Journal of Cancer 2018 被引用: 1,356

  5. Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Justin F. Gainor, Matthew D. Hellmann, Mark M. Awad - Journal of Thoracic Oncology 2021 被引用: 367

  6. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rameen Beroukhim, Pratiti Bandopadhayay, Mark M. Awad, Prafulla C. Gokhale, Paul T. Kirschmeier, Jarrod A. Marto, Fernando D. Camargo, Rizwan Haq, Cloud P. Paweletz, Kwok‐Kin Wong, David A. Barbie, Henry W. Long, Nathanael S. Gray, Pasi A. Jänne - Cancer Cell 2020 被引用: 472

  7. Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lauren Keogh, María Anguiano, Lance Stapleton, Zhiheng Jia, Michal Barzily-Rokni, Israel Cañadas, Tran C. Thai, Marc R. Hammond, Raven Vlahos, Eric S. Wang, Hua Zhang, Shuai Li, Glenn J. Hanna, Wei Huang, Mai P. Hoang, Adriano Piris, Jean-Pierre Eliane, Anat Stemmer‐Rachamimov, Lisa Cameron, Mei-Ju Su, Parin Shah, Benjamin Izar, Manisha Thakuria, Nicole R. LeBoeuf, Guilherme Rabinowits, Viswanath Gunda, Sareh Parangi, James M. Cleary, Brian C. Miller, Shunsuke Kitajima, Rohit Thummalapalli, Benchun Miao, Thanh U. Barbie, Vivek Sivathanu, Joshua A. Wong, William G. Richards, Raphael Bueno, Charles H. Yoon, Juan J. Miret, Meenhard Herlyn, Levi A. Garraway, Eliezer M. Van Allen, Gordon J. Freeman, Paul T. Kirschmeier, Jochen H. Lorch, Patrick A. Ott, F. Stephen Hodi, Keith T. Flaherty, Roger D. Kamm, Genevieve M. Boland, Kwok‐Kin Wong, David Dornan, Cloud P. Paweletz, David A. Barbie - Cancer Discovery 2017 被引用: 585

  8. CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay C. Strum, William G. Richards, Jochen H. Lorch, Sareh Parangi, Viswanath Gunda, Genevieve M. Boland, Raphael Bueno, Sangeetha Palakurthi, Gordon J. Freeman, Jerome Ritz, W. Nicholas Haining, Norman E. Sharpless, Haribabu Arthanari, Geoffrey I. Shapiro, David A. Barbie, Nathanael S. Gray, Kwok‐Kin Wong - Cancer Discovery 2017 被引用: 781

  9. Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer

    著者: , , , , , , , , , , , , , , , , - Cancer Discovery 2018 被引用: 515

  10. STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Glenn Dranoff, Peter S. Hammerman, Kwok‐Kin Wong - Cancer Research 2016 被引用: 630

  11. Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xitao Wang, Bowen Chen, Fangxin Hong, Lynette M. Sholl, Michael Tolstorukov, Kathleen L. Pfaff, Pasi A. Jänne, Evisa Gjini, Robin Edwards, Scott J. Rodig, Ellis L. Reinherz, Matthew G. Oser, David A. Barbie - Cancer Discovery 2021 被引用: 214

  12. STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models

    著者: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 被引用: 167

  13. EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Housheng Hansen He, Matthew L. Freedman, Steven P. Balk, Massimo Loda, David P. Labbé, Brian M. Olson, Leigh Ellis - Nature Cancer 2021 被引用: 241

  14. Targeting TBK1 to overcome resistance to cancer immunotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xingping Qin, Kristopher A. Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y. Su, Angelina M. Cicerchia, Martin Q. Rasmussen, Samuel J. Klempner, Dejan Juric, Sara I. Pai, David M. Miller, Anita Giobbie‐Hurder, Jonathan Chen, Karin Pelka, Dennie T. Frederick, Susanna Stinson, Elena V. Ivanova, Amir Reza Aref, Cloud P. Paweletz, David A. Barbie, Debattama R. Sen, David E. Fisher, Ryan B. Corcoran, Nir Hacohen, Peter K. Sorger, Keith T. Flaherty, Genevieve M. Boland, Robert T. Manguso, Russell W. Jenkins - Nature 2023 被引用: 167

  15. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eliezer M. Van Allen - Nature Genetics 2018 被引用: 696

  16. Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynnette Marie Sholl, Ewa Sicińska, Jacob Sands, Scott J. Rodig, Kwok‐Kin Wong, Cloud P. Paweletz, Hideo Watanabe, David A. Barbie - Nature Medicine 2018 被引用: 317

  17. TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2024 被引用: 94

  18. MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2022 被引用: 101

  19. 3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , - Lab on a Chip 2018 被引用: 251

  20. Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2019 被引用: 238

  21. Activation of Tumor-Cell STING Primes NK-Cell Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pınar Ö. Eser, Zehua Li, Israel Cañadas, Marina Vivero, Assunta De Rienzo, William G. Richards, Adnan O. Abu‐Yousif, Vicky A. Appleman, Richard C. Gregory, Alexander Parent, Neil Lineberry, Eric L. Smith, Pasi A. Jänne, Juan J. Miret, Michael Tolstorukov, Rizwan Romee, Cloud P. Paweletz, Raphael Bueno, David A. Barbie - Cancer Immunology Research 2022 被引用: 88

  22. New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay

    著者: , , , , , , , , , - Advanced Healthcare Materials 2022 被引用: 81

  23. Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark M. Awad, Jia Luo - Annals of Oncology 2022 被引用: 101

  24. Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ricardo De Matos Simoes, Matti Kankainen, Constantine S. Mitsiades, Satu Mustjoki - Immunity 2023 被引用: 66